The Effect of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients on Gastric Emptying

被引：0
|
作者：
Arai, Makoto
Oyamada, Arata
Maruoka, Daisuke
Matsumura, Tomoaki
Nakagawa, Tomoo
Kanda, Tastuo
Katsuno, Tatsuro
Imazeki, Fumio
Yokosuka, Osamu
机构：
来源：
GASTROENTEROLOGY | 2014年 / 146卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1309
引用
收藏
页码：S615 / S616
页数：2
相关论文
共 50 条
  • [31] Dermatological side-effects of telaprevir-based triple therapy for chronic hepatitis C in phase III trials in Japan
    Torii, Hideshi
    Sueki, Hirohiko
    Kumada, Hiromitsu
    Sakurai, Yuko
    Aoki, Keiji
    Yamada, Ichimaro
    Ohtsuki, Mamitaro
    [J]. JOURNAL OF DERMATOLOGY, 2013, 40 (08): : 587 - 595
  • [32] Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study
    Luisa Montes, Maria
    Nelson, Mark
    Girard, Pierre-Marie
    Sasadeusz, Joe
    Horban, Andrzej
    Grinsztejn, Beatriz
    Zakharova, Natalia
    Rivero, Antonio
    Durant, Jacques
    Ortega-Gonzalez, Enrique
    Lathouwers, Erkki
    Janssen, Katrien
    Ouwerkerk-Mahadevan, Sivi
    Witek, James
    Gonzalez-Garcia, Juan
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) : 244 - 250
  • [33] Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus
    Elsharkawy, A. M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (05) : 543 - 544
  • [34] Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation
    Ikegami, Toru
    Yoshizumi, Tomoharu
    Shirabe, Ken
    Maehara, Yoshihiko
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (04) : 894 - 896
  • [35] Viral Hepatitis ( plus Antiviral Therapy) Efficacy of telaprevir-based triple therapy for genotype 1 hepatitis patients in Japan
    Sasaki, Masato
    Yoshida, Kenichi
    Inamura, Kazuki
    Obata, Masahiro
    Yoshinari, Motonari
    Idegami, Junko
    Tanaka, Hideki
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 423 - 423
  • [36] Liver Apparent Diffusion Coefficient Changes during Telaprevir-Based Therapy for Chronic Hepatitis C
    Gurcan, Nagihan Inan
    Sakci, Zakir
    Akhan, Sila
    Altunok, Elif Sargin
    Aynioglu, Aynur
    Gurbuz, Yesim
    Sarisoy, Hasan Tahsin
    Akansel, Gur
    [J]. BALKAN MEDICAL JOURNAL, 2016, 33 (06) : 602 - 606
  • [37] Efficacy and safety of telaprevir-based triple therapy for patients aged 66 years and older with genotype 1b chronic hepatitis C
    Yamagiwa, Satoshi
    Ishikawa, Toru
    Tsubata, Shunsuke
    Waguri, Nobuo
    Sugitani, Soichi
    Wakabayashi, Hiroto
    Takamura, Masaaki
    Igarashi, Masato
    Nomoto, Minoru
    [J]. HEPATOLOGY, 2014, 60 : 691A - 692A
  • [38] Dynamic and rapid changes in viral quasispecies by UDPS in chronic hepatitis C patients receiving telaprevir-based therapy
    Trimoulet, Pascale
    Pinson, Patricia
    Papuchon, Jennifer
    Foucher, Juliette
    Vergniol, Julien
    Chermak, Faiza
    Wittkop, Linda
    Castaing, Nadege
    Merrouche, Wassil
    Reigadas, Sandrine
    Molimard, Mathieu
    Kann, Michael
    Fleury, Herve
    de Ledinghen, Victor
    [J]. ANTIVIRAL THERAPY, 2013, 18 (05) : 723 - 727
  • [39] VIROLOGICAL RESPONSE AT WEEK 6 OF TELAPREVIR-BASED TRIPLE THERAPY IS THE MOST EFFECTIVE PREDICTOR OF CHRONIC HEPATITIS C TREATMENT OUTCOME
    Hiramine, S.
    Ogawa, E.
    Furusyo, N.
    Nakamura, M.
    Kajiwara, E.
    Nomura, H.
    Dohmen, K.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Kawano, A.
    Tanabe, Y.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S474 - S474
  • [40] SERUM INTERLEUKIN-6 LEVELS DURING TREATMENT CORRELATE WITH RESISTANCE TO TELAPREVIR-BASED TRIPLE THERAPY IN CHRONIC HEPATITIS C
    Asahina, Y.
    Nakagawa, M.
    Taniguchi, M.
    Kawai, F.
    Fujiki, J.
    Otani, T.
    Yamanaka, H.
    Murakawa, M.
    Nitta, S.
    Kitazume, A.
    Watanabe, T.
    Sakurai, Y.
    Azuma, S.
    Kakinuma, S.
    Watanabe, M.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S321 - S321
12345